MedPage Today 
(8/29, Susman) reports, "Renal denervation procedures appear to
improve outcomes in patients with advanced heart failure or
treatment-resistant arterial hypertension, according to a trio of
studies presented...at the European Society of Cardiology (ESC)
meeting." Investigators found "in a pilot study," that "heart failure
patients who underwent renal denervation with radiofrequency ablation
saw an improvement in left ventricular ejection fraction (LVEF) from 25%
at baseline to 31% after 12 months (P<0.01), while patients
who received standard therapy had minimal and nonsignificant changes
from 26% at baseline to 28% at 1 year (P=0.36)." A separate study "found
that patients who underwent minimally-invasive catheter-based renal
denervation achieved blood pressure (BP) reductions that were in line
with the findings in the SIMPLICITY pilot studies." Additionally,
researchers reported positive findings from the SIMPLICITY HTN2 Trial.
No comments:
Post a Comment